CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

sklb1028

Small moleculeexperimental

Clinical trial activity

9 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
7
Phase 2
3
Phase 3
1
Phase 4
0

Earliest trial started May 1, 2016 (NCT02859948)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2019

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • sklb1028

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05072522Phase 1Oct 31, 2021Shijiazhuang Pharma Group (CSPC)
NCT05445154Phase 1/Phase 2 (Phase 2)Aug 31, 2021Shijiazhuang Pharma Group (CSPC)
NCT05369858Phase 1Aug 6, 2021Shijiazhuang Pharma Group (CSPC)
NCT05070195Phase 1Jun 7, 2021Shijiazhuang Pharma Group (CSPC)
NCT05069870Phase 1Jun 7, 2021Shijiazhuang Pharma Group (CSPC)
NCT05109663Phase 1Apr 14, 2021Shijiazhuang Pharma Group (CSPC)
NCT04716114Phase 3Mar 24, 2021Shijiazhuang Pharma Group (CSPC)
NCT04015024Phase 2Jul 31, 2019Shijiazhuang Pharma Group (CSPC)
NCT02859948Phase 1May 1, 2016Shijiazhuang Pharma Group (CSPC), Sichuan University
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Shijiazhuang Pharma Group (CSPC)For profit9932016
Sichuan UniversityAcademic/Hospital1012016
2 organizations
Page 1 / 1